CETTA, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 826
EU - Europa 764
AS - Asia 597
SA - Sud America 104
Continente sconosciuto - Info sul continente non disponibili 74
AF - Africa 17
Totale 2.382
Nazione #
US - Stati Uniti d'America 782
RU - Federazione Russa 438
SG - Singapore 211
CN - Cina 171
IT - Italia 170
BR - Brasile 80
HK - Hong Kong 66
VN - Vietnam 53
DE - Germania 28
FR - Francia 23
GB - Regno Unito 22
BD - Bangladesh 21
CA - Canada 21
FI - Finlandia 21
IN - India 20
SE - Svezia 17
MX - Messico 11
NL - Olanda 10
JP - Giappone 9
PL - Polonia 9
AR - Argentina 8
TR - Turchia 8
EC - Ecuador 6
ES - Italia 6
ZA - Sudafrica 6
ID - Indonesia 5
LT - Lituania 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
IQ - Iraq 4
IR - Iran 4
JM - Giamaica 4
PH - Filippine 4
BE - Belgio 3
CH - Svizzera 3
IE - Irlanda 3
MA - Marocco 3
NP - Nepal 3
SA - Arabia Saudita 3
UA - Ucraina 3
ZW - Zimbabwe 3
BG - Bulgaria 2
CR - Costa Rica 2
LB - Libano 2
NI - Nicaragua 2
PK - Pakistan 2
AT - Austria 1
BB - Barbados 1
BW - Botswana 1
DZ - Algeria 1
GH - Ghana 1
GT - Guatemala 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LC - Santa Lucia 1
MY - Malesia 1
NG - Nigeria 1
PY - Paraguay 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 2.308
Città #
Dallas 151
Singapore 129
Ashburn 90
San Jose 69
Moscow 67
Hong Kong 65
New York 41
Beijing 36
Council Bluffs 33
Milan 30
Los Angeles 24
Ho Chi Minh City 20
Hefei 18
Shanghai 18
Lauterbourg 17
Santa Clara 16
Phoenix 15
Orem 14
Florence 12
Rome 12
Boardman 11
Denver 10
Nuremberg 10
São Paulo 10
Turku 10
Munich 9
Warsaw 9
Tokyo 8
Ankara 7
Hanoi 7
Montreal 7
Chennai 6
Houston 6
Mexico City 6
Atlanta 5
Helsinki 5
Lappeenranta 5
Poplar 5
Rho 5
Turin 5
Washington 5
Amsterdam 4
Baguio City 4
Bologna 4
Coimbatore 4
Johannesburg 4
Manchester 4
Naples 4
Seattle 4
Stockholm 4
Tehran 4
Toronto 4
Belo Horizonte 3
Brussels 3
Da Nang 3
Dublin 3
Falkenstein 3
Genoa 3
Hackney 3
Harare 3
Latina 3
Lawrence 3
Milwaukee 3
Perugia 3
Philadelphia 3
Princeton 3
Quito 3
Baghdad 2
Barcelona 2
Bari 2
Betim 2
Biên Hòa 2
Brasília 2
Brooklyn 2
Buffalo 2
Caracas 2
Charlotte 2
Conway 2
Curitiba 2
El Paso 2
Ferrara 2
Figino 2
Frankfurt am Main 2
Guangzhou 2
Hải Dương 2
Itaúna 2
Jeddah 2
Jiaxing 2
Kingston 2
Limeira 2
Managua 2
Medellín 2
Miami 2
Mumbai 2
Nantong 2
New Delhi 2
Newark 2
Ottawa 2
Padua 2
Pescara 2
Totale 1.183
Nome #
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience 191
A novel scoring approach to identify responders to erenumab in clinical practice 187
Efficacy and safety of anti-CGRP monoclonal antibodies for chronic migraine prophylaxis in patients treated with botulinum toxin A: A prospective monocentric study 167
A 24-week prospective, multicenter, real-world study on eptinezumab’s effectiveness and safety in migraine prevention (EMBRACE II) 163
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN) 135
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study 129
Imaging the brain and vascular reactions to headache treatments: a systematic review 122
Comparison of efficacy and safety of erenumab between over and under 65-year-old refractory migraine patients: a pivotal study 117
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study 114
Correction to: Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study (Journal of Neurology, (2024), 271, 5, (2434-2443), 10.1007/s00415-023-12103-4) 100
Myocardial infarction in a patient with migraine and triptan overuse treated with anti-CGRP receptor monoclonal antibody: a case report 90
Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real‐life study 88
Stress in paediatric migraine: a trigger factor? 87
Stress related to COVID-19 pandemic as a trigger for disease activity in multiple sclerosis: a case report 87
Tracking the evolution of non-headache symptoms through the migraine attack 82
Correction: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) (The Journal of Headache and Pain, (2022), 23, 1, (46), 10.1186/s10194-022-01396-x) 77
Erenumab effect on brain network function in episodic migraine patients: a randomized, placebo-controlled, clinical trial 76
Correction to: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) (The Journal of Headache and Pain, (2022), 23, 1, (46), 10.1186/s10194-022-01396-x) 72
An Altered Hypothalamic-Pontine Functional Interplay Could Affect Migraine Disease Progression Over the Years 68
A novel scoring approach to identify responders to erenumab in clinical practice 68
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE) 61
Clinical and neuroradiological evolution of thymoma-associated anti-GABAA receptor autoimmune encephalitis: insights from a clinical case report 60
EXPLORING THE CENTRAL EFFECT OF MONOCLONAL ANTIBODIES TARGETING THE CGRP PATHWAY IN MIGRAINE PATIENTS: A MULTIMODAL MRI STUDY 24
Exploring the role of the pons and hypothalamus in migraine progression 6
Exploring the role of the pons and hypothalamus in migraine progression 6
An update on the differential diagnosis of migraine in adults: when and how neuroimaging makes the difference 5
Totale 2.382
Categoria #
all - tutte 9.788
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.788


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227 0 0 1 0 0 0 0 0 0 0 5 1
2022/202352 8 6 7 0 3 3 2 2 3 0 3 15
2023/2024161 7 16 16 14 13 27 3 16 4 4 19 22
2024/2025321 24 6 19 14 32 23 35 23 36 47 34 28
2025/20261.590 97 97 139 219 140 63 111 125 415 67 78 39
2026/2027249 131 69 49 0 0 0 0 0 0 0 0 0
Totale 2.382